Abstract
This article summarizes the ways in which a clinician should think about medication use in children and describes practical usage of the most frequently used child psychopharmacologic agents.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Grayson P, Carlson GA: The utility of a DSM-III R-based checklist in screening child psychiatric patients. J Am Acad Child and Adol Psychiatr 1991; 30:669–673
Diagnostic and Statistical Manual of Mental Disorders, Revised. Washington, D.C., American Psychiatric Association Press, 1987.
Barkley R: Attention Deficit Hyperactivity Disorder — A Handbook for Diagnoses and Treatment. New York, Guilford, 1990
Gadow K: Pediatric psychopharmacotherapy. A review of recent research. J Child Psychol and Psychiatr; Annual Review 1992; 3
Pelham WE, Walker JL, Sturges J, Hoza J: Comparative effects of methylphenidate on ADD girls and ADD boys. J Am Acad Child and Adol Psychiatr 1989; 26:773–776
Pelham WE, Greenslade KE, Vodde-Hamilton M, Murphy D, Greenstein JJ, Gragy EM, Guthrie KJ, Hoover MD, Dahl RE: Relative efficacy of long acting stimulants in children with ADHD: A comparison of standard methylphenidate, SR Methylphenidate, sustained Ritalin, Dextroamphetamine and Pemoline. J of Pediatrics 1990; 86:226–237
Malts JA, Gittelman R: Growth of hyperactive children in maintenance regimen of methylphenidate. Arch Gen Psychiatr 1983; 40:317–321
Lowe TL, Cohen DJ, Ditlas J, Kremenitzer MW, Shaywitz BA: Stimulant medications precipitated Tourette's Syndrome. JAMA 1982; 247:1729–1731
Comings DE, Comings BG: Tourette's syndrome and attention deficit disorder with hyperactivity: Are they genetically related? J Am Acad Child and Adol Psychiatr 1984; 23:138–146
Sverd J, Gadow KD, Paolicelli LM: Methylphenidate treatment of attention deficit hyperactivity disorder in boys with Tourette syndrome. J Am Acad Child and Adol Psychiatr 1989; 28:574–579
Ryan N: Heterocyclic antidepressants in children and adolescents. J Child and Adol Psychopharmacol 1990; 1:21–32
Rapoport JL, Quinn PO, Bradbard G, Riddle KD, Brooks E: Imipramine and methylphenidate treatments of hyperactive boys — a double blind comparison. Arch Gen Psychiatr 1974; 30:789–793
Quinn PO, Rapoport JL: One year followup of hyperactive boys treated with imipramine or methylphenidate. Am J Psychiatr 1975; 132:241–245
Gittelman-Klein R, Klein DF: Controlled imipramine treatment of school phobia. Arch Gen Psychiatr 1971; 25:204–207
Klein DF, Gittelman R, Quitkin F, Rifkin A: Diagnosis and Drug Treatment of Psychiatric Disorders: Adults and Children. Baltimore, Williams and Wilkins, 1980
Geller B, Cooper TB, Graham DL, Marsteller FA, Bsyant DM: Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a “fixed plasma level” design. Psychopharmacol Bulletin 1990; 26:85–90
Preskorn SH, Irwin HA: Toxicity of tricyclic antidepressants; kinetics, mechanism, intervention: A review. J Clin Psychiatr 1982; 43:151–156
Biederman J, Baldessarini R, Wright V, Knee D, Harmatz J, Goldblatt A: A double-blind placebo-controlled study of desipramine in the treatment of ADD: II Serum drug levels and cardiovascular findings. J Am Acad Child and Adol Psychiatr 1989; 28:903–911
Kovacs M, Feinberg TL, Crouse-Novak MA, Paulauskas SL, Finkelstein R: Depressive disorders in childhood. Arch Gen Psychiatr 1984: 41:229–238
Goodwin FK, Jamison KR: Manic-Depressive Illness. New York, Oxford University Press, 1990
Abramowitz M: Sudden death in children treated with tricyclic antidepressants. Drug Therapy 1990; 32:53
Tingelstad JB: The cardiotoxicity of tricyclics. J Am Acad Child and Adol Psychiatr 1991; 30:845–846
Campbell M, Godfrey KA, Magee H: Pharmacotherapy, in Handbook of Clinical Child Psychology. Edited by CE Walker. New York, Wiley and Son (in press).
Aman MG, Maras RE, Turbott SH, Wesher CP, Merry SN: Clinical effects of methylphenidate and thioridazine in intellectually subaverage children. J Am Acad Child and Adol Psychiatr 1991; 30:246–256
Richardson MH, Hangland G, Craig TJ: Neuroleptic use, Parkinsonian symptoms, tardive dykinesia, and associated factors in child and adolescent psychiatric patients. Am J Psychiatr 1991; 148:1322–1328
Carlson GA, Rapport MD, Pataki CS, Kelly KL: Lithium in hospitalized children at 4 and 8 weeks: Mood, behavior and cognitive effects. J Child Psychol and Psychiatr 1992: in press
Carlson GA: Bipolar affective disorders in childhood and adolescence, in Affective Disorders in Childhood and Adolescence. Edited by GA Carlson. New York, Spectrum Publications, 1983
Weller EB, Weller RA, Fristad MA: Lithium dosage guide for pre-pubertal children, a preliminary report. J Am Acad Child Psychiatr 1986; 25:92–95
Suppes T, Baldessarini RJ, Faedda GL, Tohen M: Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatr 1991; 48:1082–1088
Author information
Authors and Affiliations
Additional information
Leena Ranade, M.D., and Aftab Qadir, M.D., were Fellows in Child Psychiatry, State University of New York at Stony Brook at the time of writing this article.
Rights and permissions
About this article
Cite this article
Carlson, G.A., Ranade, L. & Qadir, A. Management of psychopharmacologic agents in children and adolescents. Psych Quart 63, 391–411 (1992). https://doi.org/10.1007/BF01066765
Issue Date:
DOI: https://doi.org/10.1007/BF01066765